This Fab was subsequently used to construct an anti-Trop2 IgG mAb, which inhibits tumor cell growth, migration, and invasion in vitro, and suppresses tumor proliferation in ovarian cancer xenografts 67. Here, TACSTD2 is linked to ovarian cancer.